141 related articles for article (PubMed ID: 15102965)
1. IgA nephropathy treatment 25 years on: can we halt progression? The evidence base.
Ballardie FW
Nephrol Dial Transplant; 2004 May; 19(5):1041-6. PubMed ID: 15102965
[No Abstract] [Full Text] [Related]
2. Modulating the progression in IgA nephropathy.
Chan JC; Trachtman H
Nephron Clin Pract; 2006; 104(1):c61-8. PubMed ID: 16741372
[TBL] [Abstract][Full Text] [Related]
3. [IgA nephropathy--pathogenesis, pathophysiology, and therapy].
Narita I; Goto S; Kondo D; Sakatsume M; Gejyo F
Nihon Rinsho; 2006 Feb; 64 Suppl 2():397-402. PubMed ID: 16523921
[No Abstract] [Full Text] [Related]
4. Advances in treatment: immunoglobulin A nephropathy.
Hogg RJ; Waldo B
Semin Nephrol; 1996 Nov; 16(6):511-6. PubMed ID: 9125795
[TBL] [Abstract][Full Text] [Related]
5. Therapy of patients with IgA-nephropathy: a critical appraisal.
Floege J; Mertens P
Kidney Blood Press Res; 2000; 23(3-5):207-9. PubMed ID: 11031723
[No Abstract] [Full Text] [Related]
6. Fish oil therapy in IgA nephropathy.
Fung SM; Ferrill MJ; Norton LL
Ann Pharmacother; 1997 Jan; 31(1):112-5. PubMed ID: 8997477
[TBL] [Abstract][Full Text] [Related]
7. The treatment of IgA nephropathy: status at the end of the millenium.
Glassock RJ
J Nephrol; 1999; 12(5):288-96. PubMed ID: 10630691
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic approaches in primary IgA nephropathy.
Locatelli F; Pozzi C; Del Vecchio L; Andrulli S; Bolasco P; Fogazzi G; Altieri P; Ponticelli C
Adv Nephrol Necker Hosp; 1999; 29():73-91. PubMed ID: 10561738
[No Abstract] [Full Text] [Related]
9. [IgA nephropathy: from predicting progression to treatment].
Rauta V; Grönhagen-Riska C
Duodecim; 2006; 122(2):215-22. PubMed ID: 16509071
[No Abstract] [Full Text] [Related]
10. Immunoglobulin A nephropathy: a clinical perspective.
Donadio JV; Grande JP
J Am Soc Nephrol; 1997 Aug; 8(8):1324-32. PubMed ID: 9259362
[No Abstract] [Full Text] [Related]
11. IgA nephropathy: a disease in search of a large-scale clinical trial to reliably inform practice.
Strippoli GF; Maione A; Schena FP; Tognoni G; Craig JC
Am J Kidney Dis; 2009 Jan; 53(1):5-8. PubMed ID: 19101396
[No Abstract] [Full Text] [Related]
12. Treatment of IgA nephropathy.
Julian BA
Semin Nephrol; 2000 May; 20(3):277-85. PubMed ID: 10855937
[TBL] [Abstract][Full Text] [Related]
13. IgA nephropathy.
Wardle EN
N Engl J Med; 2003 Jan; 348(1):79-81; author reply 79-81. PubMed ID: 12510692
[No Abstract] [Full Text] [Related]
14. [Treatment of IgA nephropathies: a critical viewpoint].
Mertens PR; Floege J
Dtsch Med Wochenschr; 2000 Aug; 125(34-35):1010. PubMed ID: 11004914
[No Abstract] [Full Text] [Related]
15. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
Locatelli F; Vecchio LD; Pozzi C
Nat Clin Pract Nephrol; 2006 Jan; 2(1):24-31. PubMed ID: 16932386
[TBL] [Abstract][Full Text] [Related]
16. Combined immunosuppression in high-risk patients with IgA nephropathy?
Floege J; Eitner F
J Am Soc Nephrol; 2010 Oct; 21(10):1604-6. PubMed ID: 20829408
[No Abstract] [Full Text] [Related]
17. Treatment tentatives in IgA nephropathy.
Clarkson AR; Woodroffe AJ
Semin Nephrol; 1987 Dec; 7(4):393-8. PubMed ID: 3127870
[No Abstract] [Full Text] [Related]
18. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
[TBL] [Abstract][Full Text] [Related]
19. Treating IgA nephropathy.
Dillon JJ
J Am Soc Nephrol; 2001 Apr; 12(4):846-847. PubMed ID: 11274247
[No Abstract] [Full Text] [Related]
20. Treatment of IgA Nephropathy: Evolution Over Half a Century.
Barratt J; Tang SCW
Semin Nephrol; 2018 Sep; 38(5):531-540. PubMed ID: 30177025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
